FDA NDC Directory · JSON-LD · Markdown

Cabergoline

NDC 69238-2693 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerAmneal Pharmaceuticals NY LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA218618
Dosage form / routeTABLET · ORAL
Active ingredientsCABERGOLINE (.5 mg/1)
Marketing started20241003
Package count1

External sources

Source: openFDA. Public-domain (CC0).